Stopping statins in multimorbid older adults without cardiovascular disease is a conversation many of us avoid. If STREAM shows discontinuation is non-inferior, would you raise deprescribing proactively — and with which patients?
What happened
STREAM trial tests noninferiority of statin discontinuation in multimorbid older adults without CVD.
Why the trial, key points, tables, limitations, PICO, abstract, media & sources
Expert reaction
AHA Scientific Sessions 2026
0 experts have reacted so far. We show the split once 3 have.
Expert labels are toward STREAM's result, from named public quotes (n=0). As of Oct 22, 2026.
Discontinuing statins in multimorbid older adults without cardiovascular disease: a randomized non-inferiority clinical trial (STREAM)
Discontinuing statins in multimorbid older adults without cardiovascular disease: a randomized non-inferiority clinical trial (STREAM). Session: LBS.03. Late-breaking trial at AHA Scientific Sessions 2026. Results pending.
Adam et al. (2026) studied this question. Discontinuing statins in multimorbid older adults without cardiovascular disease is being evaluated for noninferiority in the STREAM trial, with results currently pending.